Organon Pharma Indonesia Tbk. vs Agro Bahari Nusantara Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Agro Bahari Nusantara Tbk. trades at Rp595 (market cap 1.07T, 8.22M 24h volume). The key difference: Agro Bahari Nusantara Tbk. is far larger — about 10.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | UDNG | |
|---|---|---|
Market Cap | 104.4B | 1.07T |
Volume | — | 8.22M |
Lot | — | 82.24K |
Turnover | — | 4.91B |
Average Price | — | 596.69 |
Value | — | 4.91B |
Indicative Equilibrium Price | — | 595 |
Indicative Equilibrium Volume | — | 125 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Agro Bahari Nusantara Tbk (Company) was established based on Notarial Deed No. 4 on April 1, 2019 from Kezia Janty Lega, S.H., M.Kn., notary in Jakarta. The company started its commercial operations since 2019.
Read more on UDNG →